Xianping Shi

1.5k total citations
35 papers, 1.0k citations indexed

About

Xianping Shi is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Xianping Shi has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Hematology and 11 papers in Genetics. Recurrent topics in Xianping Shi's work include Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Ubiquitin and proteasome pathways (9 papers). Xianping Shi is often cited by papers focused on Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Ubiquitin and proteasome pathways (9 papers). Xianping Shi collaborates with scholars based in China, United States and Singapore. Xianping Shi's co-authors include Xiaoying Lan, Xuejun Wang, Jinbao Liu, Hongbiao Huang, Xin Chen, Chong Zhao, Ningning Liu, Jingxuan Pan, Dan Zang and Q. Ping Dou and has published in prestigious journals such as Nucleic Acids Research, Oncogene and Scientific Reports.

In The Last Decade

Xianping Shi

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianping Shi China 20 683 261 154 148 111 35 1.0k
Michelle L. Kraus United States 7 466 0.7× 447 1.7× 145 0.9× 129 0.9× 124 1.1× 9 1.1k
Peter Drueckes Switzerland 15 727 1.1× 290 1.1× 118 0.8× 96 0.6× 146 1.3× 24 1.2k
Carmen Aanei France 12 484 0.7× 219 0.8× 185 1.2× 205 1.4× 92 0.8× 22 979
Joanna Zawacka‐Pankau Sweden 19 763 1.1× 472 1.8× 88 0.6× 236 1.6× 216 1.9× 32 1.2k
Christian Borgo Italy 18 702 1.0× 224 0.9× 70 0.5× 70 0.5× 59 0.5× 38 991
Lora B. Kramer United States 22 871 1.3× 298 1.1× 230 1.5× 87 0.6× 47 0.4× 34 1.2k
Silvia Fernández de Mattos Spain 18 1.1k 1.7× 355 1.4× 114 0.7× 208 1.4× 61 0.5× 31 1.6k
Xiaoying Lan China 15 461 0.7× 227 0.9× 95 0.6× 77 0.5× 47 0.4× 20 699
Dan Zang China 18 486 0.7× 237 0.9× 60 0.4× 166 1.1× 115 1.0× 39 804

Countries citing papers authored by Xianping Shi

Since Specialization
Citations

This map shows the geographic impact of Xianping Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianping Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianping Shi more than expected).

Fields of papers citing papers by Xianping Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianping Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianping Shi. The network helps show where Xianping Shi may publish in the future.

Co-authorship network of co-authors of Xianping Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xianping Shi. A scholar is included among the top collaborators of Xianping Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianping Shi. Xianping Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jinxiang, et al.. (2023). Targeting proteasomal deubiquitinases USP14 and UCHL5 with b-AP15 reduces 5-fluorouracil resistance in colorectal cancer cells. Acta Pharmacologica Sinica. 44(12). 2537–2548. 11 indexed citations
2.
Lan, Xiaoying, Min Hu, Jiamin Wang, et al.. (2022). Piperlongumine overcomes imatinib resistance by inducing proteasome inhibition in chronic myelogenous leukemia cells. Journal of Ethnopharmacology. 301. 115815–115815. 5 indexed citations
3.
Sun, Yuening, Xin Chen, Siyan Liao, et al.. (2022). Stabilization of MYC G-quadruplex DNA by ruthenium (II) complex overcomes imatinib resistance in chronic myeloid leukemia cells harboring T315I mutation. Genes & Diseases. 10(2). 399–402. 1 indexed citations
4.
Ma, Yunxia, Xianping Shi, Zhitai Chen, et al.. (2021). Pheophorbide co-encapsulated with Cisplatin in folate-decorated PLGA nanoparticles to treat nasopharyngeal carcinoma: Combination of chemotherapy and photodynamic therapy. Colloids and Surfaces B Biointerfaces. 208. 112100–112100. 11 indexed citations
5.
Shi, Xianping, Yueyuan Zheng, Bo Zhou, et al.. (2020). EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma. Nucleic Acids Research. 48(20). 11434–11451. 26 indexed citations
6.
Yin, Liyuan, Peizhen Hu, Xianping Shi, et al.. (2020). Cancer cell’s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction. Scientific Reports. 10(1). 1216–1216. 18 indexed citations
7.
Sun, Yuening, Jinxiang Wang, Qingyan He, et al.. (2019). Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma. Journal of Experimental & Clinical Cancer Research. 38(1). 453–453. 33 indexed citations
8.
Xiao, Lu, Xiaoying Lan, Xianping Shi, et al.. (2017). Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer. Cell Death and Disease. 8(5). e2803–e2803. 66 indexed citations
9.
Lan, Xiaoying, Chong Zhao, Xin Chen, et al.. (2017). Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation. Cell Death and Disease. 8(7). e2913–e2913. 19 indexed citations
10.
Huang, Hongbiao, Ningning Liu, Chong Zhao, et al.. (2017). Bilirubin neurotoxicity is associated with proteasome inhibition. Cell Death and Disease. 8(6). e2877–e2877. 31 indexed citations
11.
Lan, Xiaoying, Chong Zhao, Xin Chen, et al.. (2016). Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms. Journal of Hematology & Oncology. 9(1). 129–129. 21 indexed citations
12.
Jiang, Lili, Dan Zang, Xiaofen Li, et al.. (2016). A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment. Scientific Reports. 6(1). 21565–21565. 26 indexed citations
13.
Zhao, Chong, Xin Chen, Dan Zang, et al.. (2016). Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy. Biochemical Pharmacology. 116. 22–38. 36 indexed citations
14.
Shi, Xianping, Xiaoying Lan, Xin Chen, et al.. (2015). Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition. Scientific Reports. 5(1). 9694–9694. 23 indexed citations
15.
Shi, Xianping, Xin Chen, Xiaofen Li, et al.. (2013). Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation. Clinical Cancer Research. 20(1). 151–163. 114 indexed citations
16.
Wu, Yongbin, Xiaoyong Sun, Xianping Shi, et al.. (2012). Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth Factor Receptor α and Bcr-Abl Oncogene Addiction in Malignant Hematologic Cells. Clinical Cancer Research. 18(7). 1966–1978. 42 indexed citations
17.
Xu, Fang, Xianping Shi, Jieshun Cui, et al.. (2010). Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl. Bioorganic & Medicinal Chemistry. 18(5). 1806–1815. 17 indexed citations
18.
Shi, Xianping, Deping Wang, Ke Ding, et al.. (2010). GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells. Cancer Biology & Therapy. 9(8). 640–650. 30 indexed citations
19.
Shi, Xianping, Yanli Jin, Chao Cheng, et al.. (2009). Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation. Clinical Cancer Research. 15(5). 1686–1697. 98 indexed citations
20.
Jin, Yanli, Qi Chen, Xianping Shi, et al.. (2009). Activity of triptolide against human mast cells harboring the kinase domain mutant KIT. Cancer Science. 100(7). 1335–1343. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle L. Kraus Breakdown of academic impact, for papers by Peter Drueckes Breakdown of academic impact, for papers by Carmen Aanei Breakdown of academic impact, for papers by Joanna Zawacka‐Pankau Breakdown of academic impact, for papers by Christian Borgo Breakdown of academic impact, for papers by Lora B. Kramer Breakdown of academic impact, for papers by Silvia Fernández de Mattos Breakdown of academic impact, for papers by Xiaoying Lan Breakdown of academic impact, for papers by Dan Zang
Rankless by CCL
2026